Intelligence Platform
Patents
Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6316197
Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the leve
expired patentUS 6316000
Cloning and expression of plasmodium falciparum transmission-blocking target antigen, PFS2
expired patentUS 6291652
Antibodies specific for proteins having polyglutamine expansions
expired patentUS 6284242
Method for enhancing myoblast migration and invasion in the context of gene therapy
expired patentUS 6277973
Cloning and expression of a DNA sequence encoding a 41 kDa cryptosporidium parvum oocyst w
expired patentUS 6271207
Enhanced expression of transgenes
expired patentUS 6262336
Expression of a heterologous protein C in mammary tissue of transgenic animals using a lon
expired patentUS 6258789
Delivery of gene products by intestinal cell expression
expired patentUS 6255289
Gene delivery by secretory gland expression
expired patentUS 6251878
Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv
expired patentUS 6251871
P16 expression constructs and their application in cancer therapy
expired patentUS 6245752
Compositions and methods for tolerization in immune complex-mediated disease progression
expired patentUS 6245560
Vector with multiple target response elements affecting gene expression
expired patentUS 6224879
Alphavirus expression vector
expired patentUS 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired patentUS 6214335
Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
expired patentUS 6210887
Methods for evaluating colon tissue for expression of the DRA (down regulated in adenoma)
expired patentUS 6197754
Suppression of tumor growth by a mini-E1A gene
expired patentUS 6197578
Cells expressing both human CD4 and a human fusion accessory factor associated with HIV in
expired patentUS 6194176
Recombinant expression of proteins from secretory cell lines
expired patentUS 6190666
DNA expression systems based on alphaviruses
expired patentUS 6183961
Methods and compositions for regulating cell cycle progression
expired patentUS 6177272
Method for treating vascular proliferative diseases with p27 and fusions thereof
expired patentUS 6165781
Modified adeno-associated virus vector capable of expression from a novel promoter
expired